Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label Trial to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcg

NCT02662764 is registered in ClinicalTrials.gov with Talphera, Inc as lead sponsor.

NCT NCT02662764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02662764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label Trial to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcg
Lead sponsor
Talphera, Inc
Phase
Phase 3
Overall status
Completed
Start date
September 28, 2016
Completion date
May 5, 2017
Enrollment
320 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

moderate-to-severe acute pain